0 items USD 0.00Search
Your search for "mp advisors prioritizing generic drug development pipeline top fifty opportunities" gave back 35374 results.
Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report Summary Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance...
MarketLine
January 2023
Price: USD 175.00
Perrigo Company plc - Strategy, SWOT and Corporate Finance Report Summary Perrigo Company plc - Strategy, SWOT and Corporate Finance Report, is a...
MarketLine
January 2023
Price: USD 175.00
STADA Arzneimittel AG - Strategy, SWOT and Corporate Finance Report Summary STADA Arzneimittel AG - Strategy, SWOT and Corporate Finance Report, is a...
MarketLine
May 2022
Price: USD 175.00
Les Laboratoires Servier - Strategy, SWOT and Corporate Finance Report Summary Les Laboratoires Servier - Strategy, SWOT and Corporate Finance Report...
MarketLine
November 2022
Price: USD 175.00
Mylan N.V. - Strategy, SWOT and Corporate Finance Report Summary Mylan N.V. - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
February 2020
Price: USD 175.00
HGH is a master hormone protein responsible for growth stimulation, development and regeneration of healthy cells. Deficiency of growth hormone leads...
Catalog:
Rockville Research
March 2017
Price: USD 1,100.00
With much-awaited approval of biosimilar interchangeability by FDA, the dynamics in the much nascent US biosimilars market is about to change with...
Catalog:
Rockville Research
January 2017
Price: USD 1,200.00
Grupo Ferrer Internacional SA - Strategy, SWOT and Corporate Finance Report Summary Grupo Ferrer Internacional SA - Strategy, SWOT and Corporate...
Catalog:
MarketLine
July 2021
Price: USD 175.00
Sanofi SA - Strategy, SWOT and Corporate Finance Report Summary Sanofi SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive...
MarketLine
September 2022
Price: USD 175.00
Vectura Group plc - Strategy, SWOT and Corporate Finance Report Summary Vectura Group plc - Strategy, SWOT and Corporate Finance Report, is a source...
MarketLine
November 2022
Price: USD 175.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Reduced Sugar Products market will undergo major changes...
Catalog:
Arsta
January 2023
Price: USD 3,490.00
Grupo Ferrer Internacional S.A. - Strategy, SWOT and Corporate Finance Report Summary Grupo Ferrer Internacional S.A. - Strategy, SWOT and Corporate...
Catalog:
MarketLine
April 2022
Price: USD 175.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Dolutegravir and Dolutegravir Generic Drugs market will...
Catalog:
Arsta
May 2023
Price: USD 4,350.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Inhalation and Nasal Spray Generic Drugs market will...
Catalog:
Arsta
January 2022
Price: USD 3,360.00
Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report Summary Sandoz International GmbH - Strategy, SWOT and Corporate Finance...
MarketLine
September 2022
Price: USD 175.00
